SBC Medical Group to Engage Investors at Five Major Conferences This September

SBC Medical Group to Engage Investors at Five Major Conferences This September

SBC Medical Group Holdings Incorporated (Nasdaq: SBC), a Medical Services Organization providing management support across diverse healthcare sectors, announced it will participate in five investor conferences during September 2026. The company will conduct presentations and hold individual meetings with institutional investors at both in-person and virtual events.

The conference schedule begins with the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026, taking place in New York City. The three-day event, running through September 16, features both in-person and virtual participation options.

SBC Medical will then attend the ArcStone Kingswood Growth Summit 2026 in Toronto on September 16, followed by the CLSA 33rd Investors' Forum in Hong Kong on September 21. The CLSA forum represents one of Asia's most established investment conferences, historically drawing over 1,000 investors and senior executives from hundreds of global companies.

The company's conference appearances will conclude with two virtual events: the Sidoti Small-Cap Virtual Conference on September 23-24, and the Lytham Partners Fall 2026 Investor Conference on September 29-30.

Company Background and Recent Milestones

SBC Medical operates as a Medical Services Organization, an administrative entity that handles non-clinical business functions including billing, revenue cycle management, human resources, IT services, and compliance support for healthcare practices. This business model enables healthcare providers to concentrate on patient care while SBC Medical manages operational aspects.

The company provides management support across multiple healthcare specialties, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, hair loss treatment, and ophthalmology. According to its full year 2024 results, SBC Medical operated a network of 251 clinics and served 6.0 million customers over twelve months, achieving a repeat customer rate exceeding 70 percent.

SBC Medical completed its Nasdaq listing through a business combination with Pono Capital Two, a special purpose acquisition company, with the transaction closing on September 17, 2024. Trading under ticker symbol SBC began the following day on September 18, 2024. At the time of listing, the company provided management services to 164 franchisee treatment centers in Japan with support from approximately 1,639 employees globally, the majority located in Japan.

In June 2025, the company achieved inclusion in the Russell 3000 Index, which measures the performance of the largest 3,000 U.S. companies by market capitalization, representing approximately 98 percent of the investable U.S. equity market. The inclusion became effective after the U.S. market close on June 27, 2025, with trading beginning June 30, 2025. As of the end of June 2025, approximately $12.2 trillion in assets are benchmarked against the Russell U.S. Indexes.

Global Expansion Strategy

The company actively expands its international presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. Guided by its Group Purpose of "Contributing to the well-being of people around the world through medical innovation," SBC Medical continues developing its portfolio of clinic brands while strengthening its reputation for quality and trust in medical care.

Registration details for each conference are available through the respective event websites, with links provided in the company's announcement.